Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome

被引:44
作者
Haddow, Lewis J. [1 ,2 ]
Dibben, Oliver [3 ]
Moosa, Mohamed-Yunus S. [2 ]
Borrow, Persephone [3 ]
Easterbrook, Philippa J. [2 ]
机构
[1] UCL, Div Infect Immun & Inflammatory Dis, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res,Mortimer Market Ctr, London WC1E 6JB, England
[2] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Infect Dis, Durban, South Africa
[3] Univ Oxford, Nuffield Dept Clin Med, Jenner Inst, Oxford, England
基金
英国医学研究理事会;
关键词
biomarker; chemokine; C-reactive protein; cytokine; HIV; immune reconstitution inflammatory syndrome; tuberculosis; ACTIVE ANTIRETROVIRAL THERAPY; CO-INFECTED PATIENTS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; RESTORATION-DISEASE; RISK-FACTORS; T-CELLS; CASE-DEFINITION; SOUTH-AFRICA; HIV; INITIATION;
D O I
10.1097/QAD.0b013e3283477d67
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To identify inflammatory biomarker profiles during paradoxical and unmasking tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS), and determine whether differences in biomarkers prior to antiretroviral therapy (ART) predict subsequent development of TB-IRIS. Design: Case-control study within a cohort of patients initiating ART in South Africa (n = 498). Methods: Participants were followed up for 24 weeks for development of TB-IRIS. Plasma samples were collected at baseline and presentation with symptoms. Groups of cases and controls were as follows: pre-ART TB and developed paradoxical TB-IRIS (n = 9); pre-ART TB but no IRIS (n = 12); no pre-ART TB but developed unmasking TB-IRIS (n = 13); no pre-ART TB and no TB or IRIS during treatment (n = 12). Concentrations of 18 cytokines and chemokines, and C-reactive protein (CRP), were measured and compared. Results: Event samples were drawn a median of 28 days after ART initiation [interquartile range (IQR) 14-56 days]. During paradoxical TB-IRIS events, there were lower median concentrations of interleukin-10 [IL-10; 22.1 (IQR 15.3-34.9) vs. 82.2 (29.4-128.4) pg/ml, P = 0.047] and monocyte chemotactic protein-1 [MCP-1; 27.6 (20.0-29.7) vs. 71.4 (40.6-77.8) pg/ml, P = 0.005], and higher CRP : IL-10 ratio [2.2 x 10(3) (1.8-3.4) vs. 0.3 x 10(3) (0.2-0.5), P = 0.003] than in controls. Patients who developed unmasking TB-IRIS had higher median pre-ART levels of CRP [25 (8-47) vs. 6 (lower limit of detection, LLD-12) mg/l, P = 0.046] and interferon gamma (IFN-gamma) [9.1 (4.4-24.7) vs. 0.9 (LLD-8.7) pg/ml, P = 0.032] than controls. Conclusion: Patients with unmasking TB-IRIS had higher pre-ART levels of plasma IFN-gamma and CRP, consistent with preexisting subclinical TB. Paradoxical TB-IRIS was associated with lower levels of biomarkers of monocyte and regulatory T-cell activity, and higher CRP. (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
引用
收藏
页码:1163 / 1174
页数:12
相关论文
共 50 条
[1]   Down-modulation of lung immune responses by interleukin-10 and transforming growth factor β (TGF-β) and analysis of TGF-β receptors I and II in active tuberculosis [J].
Bonecini-Almeida, MG ;
Ho, JL ;
Boéchat, N ;
Huard, RC ;
Chitale, S ;
Doo, H ;
Geng, JY ;
Rego, L ;
Lazzarini, LCO ;
Kritski, AL ;
Johnson, WD ;
McCaffrey, TA ;
Silva, JRLE .
INFECTION AND IMMUNITY, 2004, 72 (05) :2628-2634
[2]   Biomarkers of HIV immune reconstitution inflammatory syndrome [J].
Bonham, Shuli ;
Meya, David B. ;
Bohjanen, Paul R. ;
Boulware, David R. .
BIOMARKERS IN MEDICINE, 2008, 2 (04) :349-361
[3]  
BOULWARE DR, 2008, INF DIS SOC AM 46 AN
[4]  
BOULWARE DR, 2009, 16 C RETR OPP INF MO
[5]   Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients [J].
Bourgarit, A ;
Carcelain, G ;
Martinez, V ;
Lascoux, C ;
Delcey, V ;
Gicquel, B ;
Vicaut, E ;
Lagrange, PH ;
Sereni, D ;
Autran, B .
AIDS, 2006, 20 (02) :F1-F7
[6]   Determinants of immune reconstitution inflammatory syndrome in HIV type 1 -: Infected patients with tuberculosis after initiation of antiretroviral therapy [J].
Breton, G ;
Duval, X ;
Estellat, C ;
Poaletti, X ;
Bonnet, D ;
Mvondo, DM ;
Longuet, P ;
Leport, C ;
Vildé, JL .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (11) :1709-1712
[7]  
Burman W, 2007, INT J TUBERC LUNG D, V11, P1282
[8]   IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients [J].
De La Barrera, S ;
Alemán, M ;
Musella, R ;
Schierloh, P ;
Pasquinelli, V ;
García, V ;
Abbate, E ;
Sasiain, MD .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (01) :128-138
[9]   Monocyte Chemoattractant Protein-1 (MCP-1): An Overview [J].
Deshmane, Satish L. ;
Kremlev, Sergey ;
Amini, Shohreh ;
Sawaya, Bassel E. .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (06) :313-326
[10]   Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome [J].
Espinosa, E. ;
Pena-Jimenez, A. ;
Ormsby, C. E. ;
Vega-Barrientos, R. ;
Reyes-Teran, G. .
HIV MEDICINE, 2009, 10 (07) :454-457